| Financial Year |
March 31 2023 |
| Monetary Funds |
550,665,425.70 |
| Held-for-trading Financial Assets |
65,532,328.56 |
| Notes Receivable |
109,819,487.75 |
| Accounts Receivable |
1,076,028,825.07 |
| Advances to Suppliers |
52,066,926.86 |
| Other Receivables |
50,704,193.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
906,236.12 |
| Dividend Receivable |
-- |
| Inventories |
741,714,476.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,395,429.85 |
| Total Current Assets |
2,985,904,856.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
144,584,325.23 |
| Investment Properties |
-- |
| Fixed Assetes |
384,440,572.61 |
| Under-construction Projects |
3,442,033.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,877,041.88 |
| R&D expenses |
-- |
| Goodwill |
117,031,226.86 |
| Long-Term Deferred and Prepaid Expenses |
2,461,588.70 |
| Deferred Income Tax Assets |
80,917,007.98 |
| Other Non-Current Assets |
144,000.00 |
| Sub-Total of Non-Current Assets |
1,098,990,117.19 |
| Total Assets |
4,084,894,973.52 |
| Short-Term Loans |
192,902,515.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
331,197,431.17 |
| Accounts Payable |
509,002,024.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,496,016.79 |
| Taxes Payable |
8,188,649.19 |
| Interest Payable |
-- |
| Dividend Payable |
25,000.00 |
| Other payables |
34,280,906.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,298,951.22 |
| Other Current Liabilities |
68,857,580.68 |
| Sub-Total of Current Liabilities |
1,498,204,913.18 |
| Long-term Loans |
130,980,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,421,482.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
169,683,671.04 |
| Total Liabilities |
1,667,888,584.22 |
| Paid-In Capital(Or Share Stock) |
1,416,640,800.00 |
| Capital Surplus |
61,306,135.09 |
| Surplus Reserve |
82,587,430.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
602,984,840.17 |
| Minority Stockholder's Interest |
122,482,316.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,294,524,073.00 |
| Owner's Equity（Stockholder's Equity） |
2,417,006,389.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,084,894,973.52 |
